Defense Health Agency Contracting Activity - DHACA

Description

The FY21 VRP TRA is intended to support translational research that moves promising discoveries into clinical applications that will advance the prevention, diagnosis, mitigation, and/or treatment of eye injury or visual dysfunction associated with military-relevant trauma. Successful applications to the FY21 VRP TRA should establish a clear path to transform a discovery into new drugs, devices, or clinical practice guidelines that are ready for definitive testing in clinical trials. It is expected that, if applicable, an Investigational New Drug (IND)/ Investigational Device Exemption (IDE) application will be submitted during or by the end of the period of performance. To facilitate the preparation for IND/IDE application, the investigative team should include at least one collaborator with expertise in the U.S. Food and Drug Administration (FDA) regulatory approval process.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org